Celldemic is intended for immunizing people during outbreaks coming from animals, including when public health officials anticipate a possible pandemic.

Incellipan is intended as a pandemic preparedness vaccine to be used only when a pandemic has been declared, which prompted the manufacturer to include the pandemic strain in the final version of its vaccine. The approval now, based on safety and efficacy trials, would speed the final authorization of a pandemic vaccine.